(Q39993986)

English

Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

based on heuristic

inferred from title

transient myeloproliferative syndrome

1 reference

based on heuristic

inferred from title

Hirokazu Kanegane

6

object named as

Hirokazu Kanegane

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Tomohiko Sato

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Tsutomu Toki

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Rika Kanezaki

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Gang Xu

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Kiminori Terui

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Masayoshi Miura

7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Souichi Adachi

8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Masahiro Migita

9

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Shingo Morinaga

10

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Takahide Nakano

11

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Mikiya Endo

12

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Seiji Kojima

13

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hitoshi Kiyoi

14

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Hiroyuki Mano

15

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Etsuro Ito

16

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

language of work or name

0 references

publication date

7 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

141

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

681-688

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Natural history of GATA1 mutations in Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Identification of a constitutively active mutant of JAK3 by retroviral expression screening

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

The N-termini of FAK and JAKs contain divergent band 4.1 domains

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Comprehensive analysis of gene alterations in acute megakaryoblastic leukemia of Down's syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Origins of leukaemia in children with Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Cloning and characterization of the novel chimeric gene p53/FXR2 in the acute megakaryoblastic leukemia cell line CMK11-5.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

X-linked severe combined immunodeficiency: from molecular cause to gene therapy within seven years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Plat-E: an efficient and stable system for transient packaging of retroviruses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Activating alleles of JAK3 in acute megakaryoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Sak serine-threonine kinase acts as an effector of Tec tyrosine kinase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2008.07081.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2008.07081.X

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39993986&oldid=1882122103"